Cian Healthcare Statistics
Total Valuation
Cian Healthcare has a market cap or net worth of INR 125.23 million. The enterprise value is 567.92 million.
| Market Cap | 125.23M |
| Enterprise Value | 567.92M |
Important Dates
The last earnings date was Wednesday, January 14, 2026.
| Earnings Date | Jan 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cian Healthcare has 25.00 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 25.00M |
| Shares Outstanding | 25.00M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | n/a |
| Float | 603,677 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.54 |
| PB Ratio | 0.46 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | 1.40 |
| P/OCF Ratio | 1.39 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.35 |
| EV / Sales | 2.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 6.37 |
Financial Position
The company has a current ratio of 0.62, with a Debt / Equity ratio of 2.03.
| Current Ratio | 0.62 |
| Quick Ratio | 0.28 |
| Debt / Equity | 2.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.16 |
| Interest Coverage | -57.21 |
Financial Efficiency
Return on equity (ROE) is -39.23% and return on invested capital (ROIC) is -18.12%.
| Return on Equity (ROE) | -39.23% |
| Return on Assets (ROA) | -5.55% |
| Return on Invested Capital (ROIC) | -18.12% |
| Return on Capital Employed (ROCE) | -28.79% |
| Weighted Average Cost of Capital (WACC) | 1.17% |
| Revenue Per Employee | 1.26M |
| Profits Per Employee | -705,357 |
| Employee Count | 185 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.83 |
Taxes
In the past 12 months, Cian Healthcare has paid 560,000 in taxes.
| Income Tax | 560,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3,206.37% in the last 52 weeks. The beta is 0.12, so Cian Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +3,206.37% |
| 50-Day Moving Average | 5.86 |
| 200-Day Moving Average | 4.42 |
| Relative Strength Index (RSI) | 38.68 |
| Average Volume (20 Days) | 124,559 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cian Healthcare had revenue of INR 232.80 million and -130.49 million in losses. Loss per share was -104.43.
| Revenue | 232.80M |
| Gross Profit | 17.05M |
| Operating Income | -129.23M |
| Pretax Income | -129.93M |
| Net Income | -130.49M |
| EBITDA | -90.09M |
| EBIT | -129.23M |
| Loss Per Share | -104.43 |
Balance Sheet
The company has 107.04 million in cash and 549.73 million in debt, with a net cash position of -442.69 million or -17.71 per share.
| Cash & Cash Equivalents | 107.04M |
| Total Debt | 549.73M |
| Net Cash | -442.69M |
| Net Cash Per Share | -17.71 |
| Equity (Book Value) | 270.36M |
| Book Value Per Share | 216.39 |
| Working Capital | -386.76M |
Cash Flow
In the last 12 months, operating cash flow was 89.81 million and capital expenditures -616,000, giving a free cash flow of 89.19 million.
| Operating Cash Flow | 89.81M |
| Capital Expenditures | -616,000 |
| Free Cash Flow | 89.19M |
| FCF Per Share | 3.57 |
Margins
Gross margin is 7.33%, with operating and profit margins of -55.51% and -56.05%.
| Gross Margin | 7.33% |
| Operating Margin | -55.51% |
| Pretax Margin | -55.81% |
| Profit Margin | -56.05% |
| EBITDA Margin | -38.70% |
| EBIT Margin | -55.51% |
| FCF Margin | 38.31% |
Dividends & Yields
Cian Healthcare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.04% |
| Earnings Yield | -104.20% |
| FCF Yield | 71.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |